m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0022)
Name |
Skeletal anomaly
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: LD24
|
Full List of Target Gene(s) of This m6A-centered Disease Response
Myeloid differentiation primary response protein MyD88 (MYD88)
In total 2 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | METTL3 positively regulates expression of Myeloid differentiation primary response protein MyD88 (MYD88), a critical upstream regulator of NF-Kappa-B signaling, by facilitating m6A methylation modification to MYD88-RNA, subsequently inducing the activation of NF-Kappa-B which is widely regarded as a repressor of osteogenesis and therefore suppressing osteogenic progression. The METTL3-mediated m6A methylation is found to be dynamically reversed by the demethylase ALKBH5. | |||
Responsed Disease | Skeletal anomaly [ICD-11: LD24] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Central carbon metabolism in cancer | hsa05230 | ||
Cell Process | Glucose metabolism | |||
In-vitro Model | Mesenchymal stem cell line (NP tissues were used to isolate NP cells) | |||
Experiment 2 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | METTL3 positively regulates expression of Myeloid differentiation primary response protein MyD88 (MYD88), a critical upstream regulator of NF-Kappa-B signaling, by facilitating m6A methylation modification to MYD88-RNA, subsequently inducing the activation of NF-Kappa-B which is widely regarded as a repressor of osteogenesis and therefore suppressing osteogenic progression. The METTL3-mediated m6A methylation is found to be dynamically reversed by the demethylase ALKBH5. | |||
Responsed Disease | Skeletal anomaly [ICD-11: LD24] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Down regulation | |||
Pathway Response | Central carbon metabolism in cancer | hsa05230 | ||
Cell Process | Glucose metabolism | |||
In-vitro Model | Mesenchymal stem cell line (NP tissues were used to isolate NP cells) | |||